Growth hormone regulates the balance between bone formation and bone marrow adiposity

Journal of Bone and Mineral Research

Volumn 25, Issue 4, 2010, Pages 757-768

  Menagh, Philip J ^a   Turner, Russell T ^a   Jump, Donald B ^a,b   Wong, Carmen P ^a   Lowry, Malcolm B ^a   Yakar, Shoshana ^c   Rosen, Clifford J ^d,e   Iwaniec, Urszula T ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d ST JOSEPH HOSPITAL   (United States)

^e JACKSON LABORATORY   (United States)

Author keywords

Adipocytes; Estrogen; IGF 1; Osteoblasts; Parathyroid hormone

Indexed keywords

CHOLESTEROL; CORTISONE; ESTRADIOL; GROWTH HORMONE; MESSENGER RNA; PARATHYROID HORMONE; SOMATOMEDIN C; THYROXINE; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; BONE; BONE MARROW; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HYPOPHYSECTOMY; IN VIVO STUDY; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOLYSIS; PROTEIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ADIPOSITY; ANIMALS; BONE MARROW; CALCIFICATION, PHYSIOLOGIC; CORTISONE; ESTRADIOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPHYSECTOMY; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; THYROXINE;

EID: 77953469123     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091015     Document Type: Article

References (56)

1. Nilsson A, Swolin D, Enerback S, Ohlsson C. Expression of functional growth hormone receptors in cultured human osteoblast-like cells. J Clin Endocrinol Metab. 1995;80:3483-3488.
2. Kasukawa Y, Miyakoshi N, Mohan S. The anabolic effects of GH/IGF system on bone. Curr Pharm Des. 2004;10:2577-2592. (Pubitemid 39004078)
3. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev. 1998;19:55-79.
4. Franco C, Bengtsson BA, Johannsson G. The GH/IGF-1 axis in obesity: physiological and pathological aspects. Metab Syndr Relat Disord. 2006;4:51-56.
5. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008;535-539.
6. Joseph F, Ahmad AM, Ul-Haq M, et al. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis. J Bone Miner Res. 2008;23:721-729. (Pubitemid 351575026)
7. Stabnov L, Kasukawa Y, Guo R, et al. Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice. Bone. 2002;30:909-916. (Pubitemid 34616022)
8. Zhao G, Monier-Faugere MC, Langub MC, et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology. 2000;141:2674-2682. (Pubitemid 32269089)
9. Govoni KE, Lee SK, Chung YS, et al. Disruption of insulin-like growth factor-I expression in type IIαI collagen-expressing cells reduces bone length and width in mice. Physiol Genom. 2007;30:354-362.
10. Bikle DD, Sakata T, Leary C, et al. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res. 2002;17:1570-1578.
11. Yakar S, Rosen CJ, Beamer WG, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110:771-781.
12. Mohan S, Richman C, Guo R, et al. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology. 2003;144:929-936. (Pubitemid 36262860)
13. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol. 2004;180:247-255. (Pubitemid 38312605)
14. Mohan S, Baylink DJ. Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. J Endocrinol. 2005;185:415-420. (Pubitemid 40883386)
15. Vaananen HK. Mesenchymal stem cells. Ann Med. 2005;37:469-479.
16. Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME. Playing with bone and fat. J Cell Biochem. 2006;98:251-266.
17. Akune T, Ohba S, Kamekura S, et al. PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest. 2004;113:846-855. (Pubitemid 38544143)
18. Morita Y, Iwamoto I, Mizuma N, et al. Precedence of the shift of bodyfat distribution over the change in body composition after menopause. J Obstet Gynaecol Res. 2006;32:513-516. (Pubitemid 44410984)
19. Pei L, Tontonoz P. Fat's loss is bone's gain. J Clin Invest. 2004;113:805-806.
20. Gevers EF, Loveridge N, Robinson IC. Bone marrow adipocytes: a neglected target tissue for growth hormone. Endocrinology. 2002;143:4065-4073. (Pubitemid 35244386)
21. Davies JS, Gevers EF, Stevenson AE, et al. Adiposity profile in the dwarf rat: an unusually lean model of profound growth hormone deficiency. Am J Physiol Endocrinol Metab. 2007;292:E1483-1494.
22. Yakar S, Bouxsein ML, Canalis E, et al. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J Endocrinol. 2006;189:289-299. (Pubitemid 43757787)
23. Schmidt IU, Dobnig H, Turner RT. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology. 1995;136:5127-5134.
24. Delahunty KM, Shultz KL, Gronowicz GA, et al. Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology. 2006;147:3915-3923.
25. Wang Y, Torres-Gonzalez M, Tripathy S, Botolin D, Christian B, Jump DB. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J Lipid Res. 2008;49:1538-1552.
26. Iwaniec UT, Wronski TJ, Turner RT. Histological analysis of bone. In: Nagy LE, ed. Alcohol: Methods and Protocols. Totowa, NJ: Humana Press; 2008:325-341.
27. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159. (Pubitemid 17064313)
29. Turner RT, Wronski TJ, Zhang M, Kidder LS, Bloomfield SA, Sibonga JD. Effects of ethanol on gene expression in rat bone: transient dose-dependent changes in mRNA levels for matrix proteins, skeletal growth factors, and cytokines are followed by reductions in bone formation. Alcohol Clin Exp Res. 1998;22:1591-1599.
30. Oberbauer AM, Stiglich C, Murray JD, et al. Dissociation of body growth and adipose deposition effects of growth hormone in oMt1a-oGH transgenic mice. Growth Dev Aging. 2004;68:33-45.
31. Beswick NS, Kennelly JJ. Influence of bovine growth hormone and growth hormone-releasing factor on messenger RNA abundance of lipoprotein lipase and stearoyl-CoA desaturase in the bovine mammary gland and adipose tissue. J Anim Sci. 2000;78:412-419.
32. Flowers MT, Ntambi JM. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr Opin Lipidol. 2008;19:248-256. (Pubitemid 351653562)
33. Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of N-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond). 2009;116:1-16.
34. Appiagyei-Dankah Y, Tapiador CD, Evans JF, Castro-Magana M, Aloia JF, Yeh JK. Influence of growth hormone on bone marrow adipogenesis in hypophysectomized rats. Am J Physiol Endocrinol Metab. 2003;284:E566-573.
35. Montalto MB, Bensadoun A. Lipoprotein lipase synthesis and secretion: effects of concentration and type of fatty acids in adipocyte cell culture. J Lipid Res. 1993;34:397-407.
36. Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30:152-177.
37. Nam SY, Lobie PE. The mechanism of effect of growth hormone on preadipocyte and adipocyte function. Obes Rev. 2000;1:73-86.
38. Kidder LS, Schmidt IU, Evans GL, Turner RT. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats. Calcif Tissue Int. 1997;61:327-335.
39. Lax ER, Ghraf R, Schriefers H, Herrmann M, Petutschnigk D. Regulation of the activities of the enzymes involved in the metabolism of steroid hormones in rat liver: the effect of administration of anterior hypophyseal hormones and gonadotrophin preparations to hypophysectomized rats. Acta Endocrinol (Copenh). 1976;82:774-784.
40. Yeh JK, Chen MM, Aloia JF. Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy. Am J Physiol. 1997;273:E734-742.
41. Iwaniec UT, Boghossian S, Lapke PD, Turner RT, Kalra SP. Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice. Peptides. 2007;28:1012-1019.
42. Rickard DJ, Iwaniec UT, Evans G, et al. Bone growth and turnover in progesterone receptor knockout mice. Endocrinology. 2008;149:2383-2390.
43. Chen NX, Hausman GJ, Wright JT. Influence of thyroxine in vivo on preadipocyte development and insulin-like growth factor-I and IGF binding protein secretion in fetal stromal vascular cell cultures. Obes Res. 1996;4:357-366.
44. Iwaniec UT, Turner RT. Animal models for osteoporosis. In: Marcus R, Feldman D, Nelson D, Rosen CJ, eds. Osteoporosis, 3rd ed. Burlington, MA: Elsevier Academic Press; 2007: 991-1015.
45. Benayahu D, Shur I, Ben-Eliyahu S. Hormonal changes affect the bone and bonemarrow cells in a rat model. J Cell Biochem. 2000;79:407-415.
46. Hausman GJ, Wright JT. Cytochemical studies of adipose tissueassociated blood vessels in untreated and thyroxine-treated hypophysectomized pig fetuses. J Anim Sci. 1996;74:354-362.
47. Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, Grattan DR. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology. 2001;142:3836-3841.
48. Gronowski AM, Rotwein P. Rapid changes in gene expression after in vivo growth hormone treatment. Endocrinology. 1995;136:4741-4748.
49. Lin SC, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG. Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature. 1993;364:208-213.
50. Sjogren K, Jansson JO, Isaksson OG, Ohlsson C. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I. Minerva Endocrinol. 2002;27:299-311.
51. Wang Y, Nishida S, Boudignon BM, et al. IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res. 2007;22:1329-1337.
52. Hamrick MW, Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporos Int. 2008;19:905-912.
53. Rhee SD, Sung YY, Jung WH, Cheon HG. Leptin inhibits rosiglitazoneinduced adipogenesis in murine primary adipocytes. Mol Cell Endocrinol. 2008;294:61-69.
54. Luque RM, Huang ZH, Shah B, Mazzone T, Kineman RD. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice. Am J Physiol Endocrinol Metab. 2007;292:E891-899.
55. Abella E, Feliu E, Granada I, et al. Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings. Am J Clin Pathol. 2002;118:582-588.
56. Rosen CJ. Bone remodeling, energy metabolism, and the molecular clock. Cell Metab. 2008;7:7-10.